Literature DB >> 10763561

Fisher information for two gamma frailty bivariate Weibull models.

H Bjarnason1, P Hougaard.   

Abstract

The asymptotic properties of frailty models for multivariate survival data are not well understood. To study this aspect, the Fisher information is derived in the standard bivariate gamma frailty model, where the survival distribution is of Weibull form conditional on the frailty. For comparison, the Fisher information is also derived in the bivariate gamma frailty model, where the marginal distribution is of Weibull form.

Mesh:

Year:  2000        PMID: 10763561     DOI: 10.1023/a:1009614001583

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  2 in total

1.  Regression with frailty in survival analysis.

Authors:  C A McGilchrist; C W Aisbett
Journal:  Biometrics       Date:  1991-06       Impact factor: 2.571

Review 2.  Frailty models for survival data.

Authors:  P Hougaard
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

  2 in total
  2 in total

1.  Design of panel studies for disease progression with multiple stages.

Authors:  Wei-Ting Hwang; Ron Brookmeyer
Journal:  Lifetime Data Anal       Date:  2003-09       Impact factor: 1.588

2.  Assessment of breath volatile organic compounds in acute cardiorespiratory breathlessness: a protocol describing a prospective real-world observational study.

Authors:  Wadah Ibrahim; Michael Wilde; Rebecca Cordell; Dahlia Salman; Dorota Ruszkiewicz; Luke Bryant; Matthew Richardson; Robert C Free; Bo Zhao; Ahmed Yousuf; Christobelle White; Richard Russell; Sheila Jones; Bharti Patel; Asia Awal; Rachael Phillips; Graham Fowkes; Teresa McNally; Clare Foxon; Hetan Bhatt; Rosa Peltrini; Amisha Singapuri; Beverley Hargadon; Toru Suzuki; Leong L Ng; Erol Gaillard; Caroline Beardsmore; Kimuli Ryanna; Hitesh Pandya; Tim Coates; Paul S Monks; Neil Greening; Christopher E Brightling; Paul Thomas; Salman Siddiqui
Journal:  BMJ Open       Date:  2019-03-08       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.